Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Noha Mohamed (NPI 1447583406)

Field	Value
Entity Type	Individual
Organization	Noha Mohamed
Address	655 Dave Ward Dr Ste 103
City	Conway
State	AR
ZIP	72034
Taxonomy	Rheumatology Physician
NPI Enumerated	September 9, 2009

Payer Source	Total Paid
Medicare	$3.8M
Medicaid	$0

Key Findings

This is an infusion-heavy rheumatology practice: the top revenue drivers are high-cost biologic and injectable therapies rather than routine outpatient E&M. The largest single code is J2507 ($2M revenue, 53.9% of Medicare revenue), followed by J0129 ($834.1K, 22.1%) and J0717 ($425.6K, 11.3%), and the precomputed top-3 codes account for 87.3% of this provider's total Medicare revenue, signaling that drug administration and infusion services are the core business line.

Revenue concentration is extreme: the precomputed top-3 share of 87.3% shows the practice’s Medicare receipts are highly dependent on a small set of biologic drug codes. That concentration suggests revenue vulnerability to changes in drug pricing, utilization management, or payer coverage for these specific agents, but also indicates a clear operational focus on drug delivery and related nursing/infusion capacity.

Payer mix is effectively single-payer Medicare: total Medicare revenue is $3.8M while there is no Medicaid billing on file. The absence of Medicaid activity means payer strategy, contracting, and revenue risk are concentrated in the Medicare population and reimbursement environment.

Competitive standing on key drugs is mixed. For J0129 the provider ranks #74 of 1221 nationally (94th percentile) and is described as “notably above typical national volume,” indicating a nationally high-volume position for abatacept administration, while J2507 (rank #3 of 5, 50th percentile) is a major revenue driver by dollar amount but is characterized as a typical volume position within a very small peer set; J0717 sits at the 85th percentile (typical, unremarkable volume) suggesting above-average but not exceptional use of certolizumab.

Service-mix signals infrastructure and staffing implications: frequent use of J0129 (25.3K claims), J0717 (106.4K claims), and other infusion/administration codes such as 96413 and 96401, both flagged as “notably above typical national volume,” implies on-site infusion capacity, regular nursing administration, and drug procurement/handling capabilities rather than a purely office-based, procedure-light practice. This pattern supports expectations of inventory management, buy-and-bill workflows, and potential revenue tied to drug margins and administration fees.

Several administration and chemotherapy/infusion codes are statistical outliers versus peers and warrant attention for utilization profile: 99214 is an “extreme outlier” (rank #8966 of 479517, 98th percentile) despite being a small share of revenue (1.1K claims, $95.8K, 2.5%), and administration codes such as 96413 and 96401 are both described as “notably above typical national volume,” reflecting an unusually high intensity of billed administration encounters relative to many peers. These labels suggest differing patterns of visit complexity and infusion throughput that analysts should review for clinical and operational drivers.

Although the practice’s E&M volume generates only a modest share of total dollars, encounter-level complexity appears elevated: 99214 generates $95.8K (2.5% of Medicare revenue) and is an “extreme outlier” nationally, which is consistent with a patient panel that requires moderate medical decision making or prolonged visit time in addition to infusion services. This combination—high-intensity E&M visits plus concentrated biologic administration—points to a practice managing medically complex chronic rheumatologic patients.

Tenure and market footprint are established: the provider’s NPI was enumerated 2009-09-09 (~17 years ago), indicating long-term presence in the market. Given the $3.8M Medicare lifetime revenue and a lack of Medicaid claims, the practice appears to be a focused, Medicare-dependent rheumatology infusion service with a nationally notable position on specific biologic agents (particularly J0129) and concentrated revenue exposure to a small set of drug codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2507	Injection, pegloticase, 1 mg	800	$2,550	$2M
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	25,280	$30	$834.1K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	106,400	$1	$425.6K
J1602	Injection, golimumab, 1 mg, for intravenous use	15,700	$10	$172.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,100	$90	$95.8K
J0897	Injection, denosumab, 1 mg	4,140	$20	$78.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	610	$90	$53.8K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	630	$50	$31.1K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	90	$110	$10.5K
20611	In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe…	90	$90	$8.3K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Noha Mohamed — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2507	1	10	800	$2,540	$2M
J0129	3	20	8,960	$30	$532.4K
J0717	3	10	66,400	$1	$278.1K
J1602	7	10	15,300	$10	$185.4K
J0897	58	160	2,580	$20	$89.7K
96413	23	80	380	$90	$36.6K
99214	140	4,300	130	$70	$18.8K
99213	3,004	4,180	100	$50	$9.6K
96401	4	60	120	$50	$8.6K
20611	12	40	60	$70	$6.7K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Noha Mohamed, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Arkansas Childrens Hospital	AR	Children's Hospital	$0	$154.7M
University Of Arkansas For Medical Sciences	AR	General Practice Physician	$0	$55M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Angel One Arkansas Children's Hospital	AR	Ambulance	$0	$20.1M
Arkansas Childrens Hospital	AR	Pediatrics Physician	$0	$6.9M
Arkansas Childrens Hospital	AR	Dental Clinic/Center	$0	$1.3M
Donna Graham	AR	Allergy & Immunology Physician	$16.2K	$1.1M
Matthew Lindberg	AR	Anatomic Pathology Physician	$507.9K	$0
Terry Fletcher	AR	Pain Medicine (Anesthesiology) Physician	$419.5K	$0
Melissa Magill	GA	Pediatrics Physician	$0	$377.8K

Nearby Providers

Other providers in the same ZIP code as Noha Mohamed, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kid Success, Inc.	AR	Rehabilitation Clinic/Center	$0	$140.9M
Milestones Services, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.6M
Conway Regional Medical Center Inc	AR	General Acute Care Hospital	$0	$10.6M
Independent Living Services, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$9.8M
Counseling Associates, Inc	AR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$9.6M
Pediatrics Plus Therapy Services, LLC	AR	Developmental Disabilities Clinic/Center	$0	$7.1M
Central Arkansas Pediatrics, P.A.	AR	Pediatrics Physician	$0	$6.7M
Aaron K. Forrester Dds, PLLC	AR	Pediatric Dentistry	$0	$5.7M
Conway Childrens Clinic PA Corp	AR	Pediatrics Physician	$0	$4.8M
Arkansas Pediatrics Of Conway, PA	AR	Pediatrics Physician	$0	$3.9M

Noha Mohamed — Billing Profile & Reimbursement Data

Sign up for Noha Mohamed — Billing Profile & Reimbursement Data policy alerts

Noha Mohamed — Billing Profile & Reimbursement Data

Sign up for Noha Mohamed — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References